Nano-X Imaging Ltd. (NNOX) Key Metrics
NNOX valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $35.6M
- Enterprise value
- $31.5M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 2.3 10-yr median 37.4
- Price / book
- 0.8 10-yr median 2.0
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 1.26
NNOX key metrics, 2018–2025
Fiscal year ended December 31, 2025 · U.S. dollarsNNOX valuation Price multiples at each fiscal year-end price.
NNOX returns How much profit the business earns on the capital it uses.
NNOX per-share figures Results divided by the shares outstanding at year-end.
NNOX financial health Debt, liquidity and how easily interest is covered.
NNOX efficiency & capital use Working capital cycle and where the cash goes.
NNOX valuation history
NNOX returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
NNOX debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
NNOX price vs earnings per share
NNOX key metrics
2018–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||
| Market capitalization | $181.4M | $422.1M | $359.1M | $385.5M | $701.1M | $1.63B | — | — |
| Enterprise value | $129.7M | $356.3M | $285.1M | $312.5M | $618.1M | $1.42B | — | — |
| Price / sales | 13.9 | 37.4 | 36.3 | 44.9 | 537.6 | — | — | — |
| Price / book | 1.3 | 2.2 | 1.8 | 1.8 | 2.4 | 7.1 | — | — |
| EV / sales | 10.0 | 31.6 | 28.8 | 36.4 | 474.0 | — | — | — |
| Earnings yield | −41.4% | −12.7% | −16.9% | −27.3% | −8.8% | −2.7% | — | — |
| Free cash flow yield | −24.8% | −9.3% | −13.4% | −13.1% | −8.7% | −2.2% | — | — |
| Share price at fiscal year-end | $2.80 | $7.20 | $6.37 | $7.38 | $14.54 | $45.66 | — | — |
| Per share | ||||||||
| Revenue per share | $0.20 | $0.19 | $0.18 | $0.16 | $0.03 | $0.00 | $0.00 | $0.00 |
| Earnings per share | −$1.16 | −$0.91 | −$1.08 | −$2.01 | −$1.28 | −$1.22 | −$0.49 | −$0.06 |
| Operating cash flow per share | −$0.63 | −$0.62 | −$0.79 | −$0.83 | −$0.79 | −$0.60 | −$0.12 | −$0.11 |
| Free cash flow per share | −$0.69 | −$0.67 | −$0.85 | −$0.97 | −$1.27 | −$0.99 | −$0.12 | −$0.11 |
| Cash per share | $0.92 | $1.25 | $1.46 | $1.49 | $1.84 | $5.99 | $0.18 | $0.00 |
| Book value per share | $2.16 | $3.23 | $3.47 | $4.15 | $6.06 | $6.47 | −$0.19 | −$0.19 |
| Tangible book value per share | $1.23 | $2.03 | $2.04 | $2.26 | $2.74 | $6.47 | −$0.19 | −$0.19 |
| Capex per share | $0.06 | $0.05 | $0.06 | $0.14 | $0.48 | $0.39 | $0.00 | $0.00 |
| Debt per share | $0.12 | $0.13 | $0.15 | $0.09 | $0.12 | $0.04 | $0.01 | — |
| Shares outstanding | 64.8M | 58.6M | 56.4M | 52.2M | 48.2M | 35.7M | 45.7M | 34.2M |
| Change in shares outstanding | +10.5% | +4.0% | +7.9% | +8.3% | +35.2% | −22.0% | +33.8% | — |
| Returns & profitability | ||||||||
| Return on equity (ROE) | −45.6% | −27.8% | −29.5% | −41.4% | −23.6% | −39.2% | — | — |
| Return on invested capital (ROIC) | −45.4% | −36.6% | −37.3% | −49.1% | −42.7% | — | — | — |
| Return on assets (ROA) | −40.3% | −25.0% | −25.7% | −34.1% | −20.6% | −35.1% | −328.6% | −102.9% |
| Return on tangible assets | −73.6% | −38.2% | −44.0% | −67.8% | −30.4% | −18.4% | −190.0% | −102.9% |
| Free cash flow margin | −345.6% | −348.9% | −485.4% | −589.4% | — | — | — | — |
| Financial health | ||||||||
| Total debt | $7.9M | $7.4M | $8.4M | $4.6M | $5.8M | $1.4M | $526,000 | — |
| Cash & short-term investments | $59.6M | $73.2M | $82.4M | $77.6M | $88.7M | $213.5M | $8.1M | $5,000 |
| Net debt | −$51.8M | −$65.8M | −$74.0M | −$73.0M | −$82.9M | −$212.0M | −$7.5M | −$5,000 |
| Debt / equity | 0.06 | 0.04 | 0.04 | 0.02 | 0.02 | 0.01 | — | — |
| Debt / assets | 0.05 | 0.04 | 0.04 | 0.02 | 0.02 | 0.01 | 0.04 | — |
| Current ratio | 3.96 | 5.63 | 5.71 | 3.29 | 1.80 | 49.06 | 0.48 | 0.21 |
| Quick ratio | 3.77 | 5.52 | 5.56 | 3.19 | 1.74 | 49.06 | 0.48 | 0.21 |
| Interest coverage | — | — | — | -1.8 | -30.7 | -406.7 | — | -380.8 |
| Working capital | $49.9M | $64.7M | $73.1M | $57.4M | $42.1M | $215.3M | −$10.6M | −$6.5M |
| Invested capital | $88.0M | $123.4M | $121.5M | $143.7M | $209.2M | $18.7M | −$16.3M | −$6.4M |
| Tangible asset value | $79.5M | $119.1M | $114.9M | $118.0M | $132.0M | $230.7M | −$8.8M | −$6.4M |
| Net current asset value | $44.4M | $57.8M | $65.5M | $45.2M | $23.8M | $214.4M | −$11.0M | −$6.5M |
| Graham net-net per share | $0.62 | $0.93 | $1.09 | $0.81 | $0.42 | $5.84 | −$0.28 | −$0.24 |
| Capital allocation | ||||||||
| Capex / revenue | 32.3% | 24.5% | 33.3% | 83.6% | 1,775.9% | — | — | — |
| Capex / depreciation | 0.36 | 0.24 | 0.28 | 0.62 | 10.10 | 67.00 | 2.36 | 2.09 |
| Stock-based compensation / revenue | 32.2% | 64.4% | 69.0% | 217.1% | 1,442.2% | — | — | — |
| R&D / revenue | 147.7% | 178.9% | 263.0% | 309.0% | 1,313.0% | — | — | — |
| SG&A / revenue | 208.1% | 228.2% | 286.7% | 531.9% | 3,201.1% | — | — | — |
| Efficiency | ||||||||
| Days sales outstanding | 53.5 | 53.2 | 45.3 | 43.1 | 147.1 | — | — | — |
| Days of inventory on hand | 32.3 | 32.1 | 52.8 | 65.4 | 405.6 | — | — | — |
| Days payables outstanding | 36.0 | 46.0 | 76.6 | 79.7 | 231.3 | 798.4 | 1,918.0 | 855.1 |
| Cash conversion cycle (days) | 49.8 | 39.3 | 21.5 | 28.9 | 321.4 | — | — | — |
| Receivables turnover | 6.82 | 6.86 | 8.05 | 8.46 | 2.48 | — | — | — |
| Payables turnover | 10.13 | 7.94 | 4.77 | 4.58 | 1.58 | 0.46 | 0.19 | 0.43 |
| Inventory turnover | 11.31 | 11.38 | 6.92 | 5.58 | 0.90 | — | — | — |
| Asset turnover | 0.07 | 0.05 | 0.04 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average receivables | $1.9M | $1.6M | $1.2M | $1.0M | $525,500 | $0 | — | — |
| Average payables | $2.5M | $2.8M | $3.5M | $3.4M | $1.8M | $455,000 | $278,500 | $82,000 |
| Average inventory | $2.3M | $1.9M | $2.4M | $2.8M | $3.1M | — | — | — |
| Intangibles / total assets | 37.1% | 33.3% | 36.9% | 38.8% | 44.1% | 0.0% | 0.0% | 0.0% |
Computed from NNOX's annual financial statements (latest annual report filed April 30, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
NNOX valuation and financial ratios
Nano-X Imaging earned a return on equity of −45.6% and a return on invested capital of −45.4% in fiscal 2025. It ended the year with $7.9 million of debt and $59.6 million in cash and short-term investments, a net cash position of $51.8 million. The share count rose 89.6% from 34.2M to 64.8M over 7 years.
See the NNOX income statement, the NNOX chart for price history, or the NNOX stock overview for the latest quote and news.
NNOX key metrics FAQ
What is Nano-X Imaging's return on equity?
Nano-X Imaging's return on equity (ROE) was −45.6% in fiscal 2025: net income of -$75.0 million on average shareholders' equity of $164.4 million.
What is Nano-X Imaging's ROIC?
Nano-X Imaging's return on invested capital was −45.4% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Nano-X Imaging have?
Nano-X Imaging had total debt of $7.9 million at the end of fiscal 2025, a debt-to-equity ratio of 0.06 and more cash than debt.
What is Nano-X Imaging's free cash flow yield?
Nano-X Imaging generated -$45.0 million of free cash flow in fiscal 2025, a free cash flow yield of −24.8% on its market value at year-end ($181.4 million).
What is Nano-X Imaging's current ratio?
Nano-X Imaging's current ratio was 3.96 at the end of fiscal 2025: current assets were 3.96 times current liabilities.